Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $139.41 USD
Change Today -0.14 / -0.10%
Volume 1.1M
As of 8:10 PM 08/31/15 All times are local (Market data is delayed by at least 15 minutes).

sigma-aldrich (SIAL) Key Developments

Sigma-Aldrich Corporation Announces Agreement with Public Health England to Manufacture and Supply NCTC/NCPF Certified Reference Materials

Sigma-Aldrich Corporation announced it has signed an agreement with Public Health England to manufacture and supply bacterial and fungal NCTC/NCPF Certified Reference Materials in LENTICULE disc format worldwide for use as controls in food, water, environmental and clinical testing microbiology laboratories. Each CRM LENTICULE disc consists of a stipulated level of a pure culture of viable bacteria or fungi in a control-dried water-soluble matrix. The bacterial and fungal strains are prepared directly from strains selected from PHE's National Collection of Type Cultures and National Collection of Pathogenic Fungi.

Sigma-Aldrich Corporation Declares Quarterly Dividend, Payable on September 15, 2015

Sigma-Aldrich Corporation announced a quarterly cash dividend of $0.23 per share. On August 24, 2015, the company's Board of Directors conditionally approved this dividend to shareholders of record on September 1, 2015. Payment of this dividend will be made on September 15, 2015, so long as the transaction by which Merck KGaA is to acquire all of the outstanding shares of the company has not closed on that date or a date prior thereto.

Sigma-Aldrich Corporation(NasdaqGS:SIAL) dropped from NASDAQ-100 Index

Sigma-Aldrich Corporation will be removed from NASDAQ-100 Index.

Sigma-Aldrich Corporation Announces Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended June 30, 2015

Sigma-Aldrich Corporation announced unaudited consolidated earnings results for the second quarter and six months ended June 30, 2015. For the quarter, the company reported sales of $697 million compared to $701 million a year ago. Operating income was $169 million compared to $184 million a year ago. Income before income taxes was $168 million compared to $184 million a year ago. Net income was $120 million or $0.98 per diluted share $133 million or $1.11 per diluted share a year ago. Adjusted net income was $123 million or $1.01 per diluted share compared to $133 million or $1.11 per diluted share a year ago. Adjusted operating income was $173 million compared to $185 million a year ago. For the six months, the company reported sales of $1,373 million compared to $1,390 million a year ago. Operating income was $344 million compared to $358 million a year ago. Income before income taxes was $343 million compared to $357 million a year ago. Net income was $246 million or $2.02 per diluted share $259 million or $2.16 per diluted share a year ago. Adjusted net income was $251 million or $2.06 per diluted share compared to $260 million or $2.17 per diluted share a year ago. Adjusted operating income was $351 million compared to $360 million a year ago. Net cash provided by operating activities was $307 million compared to $287 million a year ago. Capital expenditures were $55 million compared to $55 million a year ago. Free cash flow for the first six months of 2015 was $252 million, of which $55 million was returned to shareholders through dividends.

GenapSys, Inc. Partners with Sigma-Aldrich Corporation

GenapSys, Inc. has partnered with Sigma-Aldrich Corporation to co-market GenapSys' Gene Electronic Nano-Integrated Ultra-Sensitive (Genius(TM)) system, a personal deoxyribonucleic acid (DNA) sequencer.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
SIAL:US $139.41 USD -0.14

SIAL Competitors

Market data is delayed at least 15 minutes.

Company Last Change
CR Bard Inc $193.79 USD -3.68
Dr Reddy's Laboratories Ltd 4,219 INR -83.65
International Flavors & Fragrances Inc $109.55 USD -1.41
UCB SA €65.66 EUR -1.88
Waters Corp $121.38 USD -3.43
View Industry Companies
 

Industry Analysis

SIAL

Industry Average

Valuation SIAL Industry Range
Price/Earnings 34.7x
Price/Sales 6.0x
Price/Book 5.1x
Price/Cash Flow 34.3x
TEV/Sales 5.5x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SIGMA-ALDRICH, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.